Davies Angela M. 4
4 · OSI PHARMACEUTICALS INC · Filed Jun 9, 2010
Insider Transaction Report
Form 4
Davies Angela M.
Sr. VP and CMO, Oncology
Transactions
- Disposition to Issuer
Common Stock
2010-06-07$57.50/sh−16$920→ 0 total
Footnotes (1)
- [F1]Represents the number of shares of common stock that were canceled in exchange for a cash payment of $57.50 per share following the merger of Ruby Acquisition, Inc. with and into OSI Pharmaceuticals, Inc.